Gentronix Limited Company Profile

23:32 EST 14th December 2018 | BioPortfolio

Gentronix helps to accelerate the pace of drug discovery by easing or removing bottlenecks in pre-clinical research. Its first product is a test to screen new pharmaceuticals for genotoxicity and cytotoxicity.

Gentronix's genotoxicity reporter system is a high-throughput eukaryotic assay that precedes the standard test battery for genotoxicity. It is a rapid, economical means of filtering out new drug candidates that would otherwise, at considerable expense, fail regulated genotoxicity testing.

Gentronix systems generate information in high-throughput mode, using standard laboratory automation, and offer the opportunity for customers to eliminate candidate compounds very early in the drug discovery process.


The Fairbairn Building, 72 Sackville Street
M60 1QD
United Kingdom


Phone: +44 (0) 161 200 3126
Fax: +44 (0) 161 200 3052

News Articles [39 Associated News Articles listed on BioPortfolio]

Gentronix extends distribution of Litron Laboratories Microflow® range of Products to Japan

Gentronix Limited, the leading specialist genotoxicity company, and Litron Laboratories, leader in flow cytometry based micronucleus detection are pleased to announce the extension of Gentronix’...

Gentronix Wins Research Grant

Biotech firm Gentronix, a Manchester University spin-out, has been awarded a grant of £147,552 by the Medical Research Council (MRC) and the Technology Strategy Board.The Manchester company wi...

Gentronix achieves prospective membership of the UK GLP compliance monitoring programme

This means that, from 22nd July 2014, GLP compliance can be claimed for work conducted by Gentronix. The company is currently able to offer the GLP assays defined in the OECD Guidelines for the Testi...

Gentronix Extends Toxicology Screening Services to Apoptosis

Apoptosis, or programmed cell death, is used by the body to remove unwanted, damaged or senescent cells from tissues. Gentronix, specialists in genotoxicity testing, announces the expansion of its ser...

Gentronix Announces Strategic Intent to Provide GLP Services

GLP is a quality system of management controls for research laboratories to ensure the quality and reliability of test data from non-clinical safety studies. Specifically, these are studies to examine...

Gentronix now offers the in vivo micronucleus testing of rodent blood samples using flow cytometry

The rodent peripheral blood micronucleus test provides an assessment of the ability of a test compound to induce chromosomal damage or mis-segregation in haematopoietic cells in rodent bone marrow. Du...

New Research Validates Miniaturisation of Micronucleus Testing for Genotoxicity by 96-well Plate Flow Cytometry

The inclusion of the micronucleus test in the recent ICH revision to the guidelines on genotoxicity is evidence of the benefits of using this assay as an alternative to the traditional Chromosome Abe...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [88 Associated Companies listed on BioPortfolio]

Gentronix Limited Manchester

Gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries. Our primary focu...

Gentronix Limited

Gentronix helps to accelerate the pace of drug discovery by easing or removing bottlenecks in pre-clinical research. Its first product is a test to screen new pharmaceuticals for genotoxicity and cyto...

Gentronix Ltd.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Gentronix Limited" on BioPortfolio

We have published hundreds of Gentronix Limited news stories on BioPortfolio along with dozens of Gentronix Limited Clinical Trials and PubMed Articles about Gentronix Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gentronix Limited Companies in our database. You can also find out about relevant Gentronix Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Corporate Database Quicklinks

Searches Linking to this Company Record